COR
Cencora, Inc.Recent alerts on COR
All signals →
Insider trade
Purchase by DURCAN DERMOT MARK
4d ago
News
Cencora appoints Eva Boratto as CFO, reaffirms guidance
6d ago
News
Cencora raises earnings outlook on share repurchases
11d ago
News
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook
14d ago
News
Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings
14d ago
News
Cencora (COR) Stock Nosedives: Here's What Caused the Decline
14d ago
News
Cencora (COR) Gains 13.2% YTD: What's Driving the Stock?
14d ago
News
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
14d ago
News
Most healthcare companies report higher Y/Y EPS in strong earnings week
24d ago
News
Cencora declares $0.60 dividend
27d ago
News
Cencora gives mixed Q2 numbers, guides FY EPS above consensus
27d ago
SEC filing
COR Acquires EyeSouth Retina Business for $1.1B, Reaffirms 2026 Guidance, Slight EPS Accretion
71d ago
SEC filing
COR Retires CFO Cleary, Reaffirms FY26 EPS Guidance
77d ago
News
Cencora’s animal health unit to merge with Covetrus in $3.5B transaction
104d ago
SEC filing
COR Announces $3.5B MWI Animal Health Merger, $1.25B Cash, $800M Preferred, 34.3% Stake
104d ago
Insider trade
Sale by Robert P. Mauch
104d ago
SEC filing
COR Sells $3.0B Senior Notes, $500M 3.950% 2029 Notes, $500M 4.250%
108d ago
News
Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056 – Compa
111d ago
News
Cencora prices $3B in senior notes across multiple maturities
111d ago
News
Cardinal Health surges following quarterly earnings beats, guidance raise
117d ago
News
Cencora outlines 11.5%-13.5% operating income growth for 2026 while integrating OneOncology
117d ago
News
Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss
118d ago
News
Lower-Than-Expected Service Bookings Impacted Certara (CERT) in Q4
126d ago
News
CereVasc Completes Enrollment of ETCHES Study of the eShunt® System for the Treatment of Communicating Hydrocephalus
132d ago
News
Novo’s CEO Is Ready to Go ‘Very Big’ in Hunt for Obesity Deals
139d ago
Get push alerts for COR
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS